Skip to main content
Pangen Biotech Inc. logo

Pangen Biotech Inc. — Investor Relations & Filings

Ticker · 222110 ISIN · KR7222110009 KO Manufacturing
Filings indexed 333 across all filing types
Latest filing 2023-04-20 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 222110

About Pangen Biotech Inc.

https://pangen.com/layout/eng/home.php

Pangen Biotech Inc. is a biotechnology company specializing in the research, development, and manufacturing of biopharmaceuticals. The company utilizes its proprietary platform technologies, particularly those based on Chinese Hamster Ovary (CHO) cell lines, for the production of complex protein therapeutics. Its primary business activities include the development of a pipeline of biosimilar products, such as Erythropoietin (EPO) and Aflibercept. In addition to its own product pipeline, Pangen Biotech offers Contract Development and Manufacturing Organization (CDMO) services, providing expertise in cell line development and biopharmaceutical production to other firms. The company also supplies reagents and kits for research applications.

Recent filings

Filing Released Lang Actions
증권발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal announcement regarding the results of a securities issuance (specifically a private placement of convertible bonds). It details the issuance amount, payment date, and the nature of the securities. This falls under the category of capital and financing updates, specifically related to the issuance of debt/equity instruments.
2023-04-20 Korean
주요사항보고서(전환사채권발행결정)
Capital/Financing Update Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding the issuance of convertible bonds (전환사채권 발행결정). This type of regulatory filing details the terms of financing, including interest rates, conversion prices, and use of proceeds. It falls under the category of capital and financing updates.
2023-04-18 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). It details the shareholding changes of a major shareholder (Huons Co., Ltd.) in the issuing company (Pangen Co., Ltd.). This is a standard regulatory filing for insider/major shareholder transactions, which falls under the 'Director's Dealing' (DIRS) category in the provided schema.
2023-03-28 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership by a major shareholder (Huons Co., Ltd.) in the issuer (Pangen Co., Ltd.). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2023-03-28 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an official announcement of the results of a General Meeting of Shareholders (정기주주총회결과). It details the approval of financial statements, dividend resolutions, and the election of directors. This falls under the category of Declaration of Voting Results & Voting Rights Announcements, as it reports the outcome of shareholder votes at the AGM.
2023-03-24 Korean
사업보고서 (2022.12)
Annual Report Classification · 100% confidence The document is a comprehensive 'Business Report' (사업보고서) for PanGen (주)팬젠, covering the 13th fiscal year (2022.01.01-2022.12.31). It contains detailed financial information, business operations, management structure, and shareholding details. This is the standard format for an annual financial filing in South Korea, which corresponds to the 10-K category in the provided classification system. FY 2022
2023-03-16 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.